Philip Morris (PM) Q3 2024 Earnings Report

Philip Morris International reported a strong Q3 2024, led by double-digit momentum in the smoke-free portfolio and solid pricing across combustibles. Organic revenue rose 11.6% year over year, underpinned by a 2.9% shipment increase and a favorable mix shift toward IQOS, ZYN, and VEEV. Smoke-free revenues grew 16.8% organically with gross margins expanding around 200 bps year-to-date, contributing to a margin expansion of 90 bps in organic operating income and 110 bps in dollar terms. Management raised full-year guidance on volume, organic OI growth, and currency-neutral EPS, signaling confidence in continued strong top-line growth and cost discipline despite a modest currency headwind. The quarter featured meaningful execution across regions—Japan, Europe, and other international markets—along with ongoing capacity expansion for ZYN and continued development of IQOS ILUMA pilots. On the balance sheet, PMI generated substantial operating cash flow ($3.34B) and ended Q3 with $4.26B of cash and equivalents, while maintaining aggressive debt levels and a negative equity position driven by high financial leverage. The company faces near-term regulatory and competitive headwinds, including EU flavor ban transitions and ongoing illicit trade risks, but remains focused on a disciplined smoke-free transformation and capital allocation to deleveraging and shareholder returns.